Vitexin Protects Against Scopolamine-Induced Cognitive Impairment by Preserving Synaptic Integrity and Modulating Nrf2/HO-1 and NF-κB Signaling Pathways
Molecular Neurobiology · 2026
DOI: 10.1007/s12035-026-05947-0 ↗Kurz gefasst
Fachartikel in der Zeitschrift Molecular Neurobiology, 2026. Verfasst von Caner Yildirim und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Physiology, Faculty of Medicine, Gaziantep University, Gaziantep, Turkey. caneryildirim27@gmail.com. Hauptthemen laut MEDLINE: Apigenin, NF-kappa B, Signal Transduction, NF-E2-Related Factor 2. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 82 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Gaziantep University.
Abstract (Originalsprache)
Alzheimer’s disease is characterized by progressive cognitive decline driven by oxidative stress, neuroinflammation, and synaptic dysfunction. This study investigated the neuroprotective effects of vitexin in a scopolamine (Sco)–induced rat model of cognitive impairment. Forty-two male Wistar rats were randomly assigned to six groups ( n = 7 per group): saline, Sco (2 mg/kg/day, i.p.), Sco + vitexin (30 mg/kg/day, oral), Sco + donepezil (1.5 mg/kg/day, i.p.), vitexin alone, and donepezil alone. All treatments were administered for 14 consecutive days. Behavioral assessments using the morris water maze and elevated plus maze revealed that Sco significantly impaired spatial learning and memory while increasing anxiety-like behaviors. Vitexin treatment markedly improved these deficits, with efficacy comparable to donepezil. Biochemically, Sco elevated acetylcholinesterase activity, lipid peroxidation, and oxidative/nitrosative stress markers (TOS, OSI, MDA, Peroxynitrite, NO, and NOS) while decreasing total antioxidant status (TAS). Vitexin reversed these changes. Western blot and immunofluorescence analyses demonstrated that Sco reduced hippocampal BDNF, GDNF, PSD95, and synaptophysin levels and increased GFAP, IL-6, TNF-α, NF-κB p65, and COX-2 expression. Vitexin restored neurotrophic and synaptic proteins, suppressed astrocyte activation and inflammatory signaling, and activated the Nrf2/HO-1 pathway. These findings were further supported by qRT-PCR analysis of BDNF, GDNF, GPX4, and NF-κB. In conclusion, vitexin exerts significant neuroprotective and synaptoprotective effects against Sco-induced cognitive impairment by simultaneously restoring redox balance, suppressing neuroinflammation, and preserving synaptic integrity. These results position vitexin as a promising therapeutic candidate for neurodegenerative disorders, including Alzheimer’s disease.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Physiology, Faculty of Medicine, Gaziantep University, Gaziantep, Turkey. caneryildirim27@gmail.com.
- Department of Physiology, Faculty of Medicine, Gaziantep University, Gaziantep, Turkey.
- Faculty of Health Sciences, Department of Nutrition and Dietetics, Gaziantep University, Gaziantep, Turkey.
- Department of Medical Biochemistry, Gaziantep Islamic University of Science and Technology, Gaziantep, Turkey.
Förderung
- Gaziantep University
Zitieren
APA
Yildirim, C., Cevik, S., Bal, R., Kaplan, D. S., Yilmaz, S. G., Ulusal, H., & Bekerecioglu, S. (2026). Vitexin Protects Against Scopolamine-Induced Cognitive Impairment by Preserving Synaptic Integrity and Modulating Nrf2/HO-1 and NF-κB Signaling Pathways. Molecular Neurobiology. https://doi.org/10.1007/s12035-026-05947-0
Vancouver
Yildirim C, Cevik S, Bal R, Kaplan DS, Yilmaz SG, Ulusal H, et al. Vitexin Protects Against Scopolamine-Induced Cognitive Impairment by Preserving Synaptic Integrity and Modulating Nrf2/HO-1 and NF-κB Signaling Pathways. Molecular Neurobiology. 2026. doi:10.1007/s12035-026-05947-0
BibTeX
@article{Yildirim2026,
author = {Yildirim, Caner and Cevik, Sena and Bal, Ramazan and Kaplan, Davut Sinan and Yilmaz, Senay Gorucu and Ulusal, Hasan and Bekerecioglu, Saadet},
title = {Vitexin Protects Against Scopolamine-Induced Cognitive Impairment by Preserving Synaptic Integrity and Modulating Nrf2/HO-1 and NF-κB Signaling Pathways},
journal = {Molecular Neurobiology},
year = {2026},
doi = {10.1007/s12035-026-05947-0}
}
EUVIMED